KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Abbott Laboratories (ABT) Shares Repurchased (2016 - 2025)

Abbott Laboratories' Shares Repurchased history spans 17 years, with the latest figure at $302.0 million for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 4.13% year-over-year to $302.0 million; the TTM value through Dec 2025 reached $893.0 million, down 31.04%, while the annual FY2025 figure was $893.0 million, 31.04% down from the prior year.
  • Shares Repurchased for Q4 2025 was $302.0 million at Abbott Laboratories, down from $305.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.3 billion in Q1 2022 and bottomed at $2.0 million in Q3 2023.
  • The 5-year median for Shares Repurchased is $310.0 million (2024), against an average of $475.4 million.
  • The largest annual shift saw Shares Repurchased crashed 99.75% in 2023 before it soared 37450.0% in 2024.
  • A 5-year view of Shares Repurchased shows it stood at $974.0 million in 2021, then decreased by 29.67% to $685.0 million in 2022, then tumbled by 62.19% to $259.0 million in 2023, then rose by 21.62% to $315.0 million in 2024, then decreased by 4.13% to $302.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Shares Repurchased are $302.0 million (Q4 2025), $305.0 million (Q3 2025), and $6.0 million (Q2 2025).